R. Matsushita

发表

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

Ryosuke Matsushita, T. Sakaguchi, H. Yoshino, 2017, British Journal of Cancer.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma

Y. Okamoto, N. Seki, Mayuko F Kato, 2015, Journal of Human Genetics.

Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients

T. Sakaguchi, H. Yoshino, R. Matsushita, 2022, International journal of nephrology.

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer

N. Seki, R. Matsushita, T. Itesako, 2015, British Journal of Cancer.

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer

N. Seki, Mayuko F Kato, R. Matsushita, 2016, British Journal of Cancer.

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma

N. Seki, K. Yamazaki, Y. Ishida, 2016, Oncotarget.

MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.

Tomohiko Ichikawa, Ryosuke Matsushita, Shinichi Sakamoto, 2015, International journal of oncology.

Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer

N. Seki, H. Yoshino, M. Yonemori, 2016, British Journal of Cancer.

Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C

N. Seki, H. Inoue, R. Matsushita, 2014, Journal of Human Genetics.

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer

N. Seki, R. Matsushita, T. Itesako, 2014, International journal of oncology.

The role of microRNAs in bladder cancer

H. Yoshino, R. Matsushita, M. Nakagawa, 2016, Investigative and clinical urology.

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma

N. Seki, H. Inoue, Mayuko F Kato, 2015, International journal of oncology.

Tumour‐suppressive microRNA‐29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma

Ryosuke Matsushita, Tomoaki Ishihara, N. Seki, 2015, FEBS letters.

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker

N. Seki, K. Yamazaki, Y. Ishida, 2015, British Journal of Cancer.

Tumor‐suppressive microRNA‐223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer

N. Seki, S. Sakamoto, Mayuko F Kato, 2015, Cancer science.

Tumour‐suppressive microRNA‐24‐1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer

N. Seki, H. Yoshino, R. Matsushita, 2014, FEBS letters.

Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): inhibition of bladder cancer cell aggressiveness

N. Seki, H. Yoshino, M. Yonemori, 2016, Oncotarget.

Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer

N. Seki, H. Yoshino, M. Yonemori, 2016, Cancer science.

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

T. Sakaguchi, H. Yoshino, M. Yonemori, 2018, British Journal of Cancer.

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer

Tomohiko Ichikawa, Ryosuke Matsushita, N. Seki, 2016, Journal of Human Genetics.

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma

N. Seki, Mayuko F Kato, R. Matsushita, 2016, International journal of oncology.

Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor

A. Tanimoto, T. Sakaguchi, H. Yoshino, 2023, FEBS open bio.

Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma

Y. Okamoto, N. Seki, R. Matsushita, 2016, Journal of Human Genetics.

Abstract B15: MicroRNA-145/145* as a dual tumor-suppressor targeting UHRF1 in bladder cancer

N. Seki, H. Yoshino, M. Yonemori, 2016 .

Long-term hemodialysis patient associated with renal capillary hemangioma originating from acquired cystic disease of the kidney : A case report

Misa Shimoinaba, T. Sakaguchi, R. Matsushita, 2015 .

The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.

Y. Okamoto, N. Seki, Mayuko F Kato, 2016, International journal of oncology.

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer

N. Seki, Mayuko F Kato, M. Yonemori, 2016, International journal of oncology.

Successful Complete Resection and Recurrence-Free Outcome in Renal Cell Carcinoma with Vena Cava Tumor Thrombus: Neoadjuvant Immune Checkpoint Inhibitor (ICI)-Based Combination Therapies

T. Sakaguchi, H. Yoshino, R. Matsushita, 2023, Current Problems in Cancer: Case Reports.

Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.

T. Sakaguchi, H. Yoshino, R. Matsushita, 2022, Biochemical and biophysical research communications.

Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients

H. Yoshino, R. Matsushita, S. Tatarano, 2023, PloS one.

Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models.

H. Yoshino, R. Matsushita, S. Tatarano, 2024, Molecular oncology.